Dr. M Farid Khan, MD
- ABIM (U.S.A)
- Cardiovascular Diseases
- Interventional Cardiology
- Cardiac Arrhythmia Management
- Heart Failure Specialist
Dr. Farid Khan, a highly experienced medical professional with over 35 years of expertise, has built a distinguished practice in the USA. Now, he is extending his exceptional healthcare services to patients at Ultramed Medical Facility, conveniently located on Shahra-e-Quaideen.
Qualifications/Trainings
Cardiovascular Fellowship (University of Colorado, Health Science Center, USA)
Interventional Fellowship (University of Colorado, Health Science Center, USA)
Heart Failure Fellowship (University of Utah, Health Science Center, USA)
Laboratory and Clinical Research Experience (USA)
Services
Cardiology Consultation (General Evaluation, murmurs, coronary heart disease, heart attack, hypertension, lipid management, cardiac fitness)
Angioplasty/Stents/Angiography
Angiojet and Thrombus/Extraction
Pacemakers and Defibrillator Implants
Arrythmia Management
Certified in (2D/3D) Echo & Nuclear Imaging
Specialized Heart Failure Management
CO2 Consumption (VO2) and Cardio Pulmonary Evaluation
EECP Service (Non-surgical bypass)
Peripheral Vascular System Evaluation and Services
Cardiac Fitness, Exercise and Rehabilitation Evaluation
Affiliations
AMA – American Medical Association, USA
NMA – Nebraska Medical Association, USA
ASE – American Society of Echocardiography, USA
PMA – Pakistan Medical Association, Pakistan
GMC, UK
Research Activities
Drug trails for Carvedilol, OPC-8212 (Vesnerinone), Bucindolol and OPC – 18790. It included making intra-coronary measurements in patients on OPC-18790.
Meta-analysis of the heart transplant patient population in assessing incidence of rejection related to age of the recipient or the donor.
Measuring effects of ‘Systemic’ and ‘Intra-Coronary’ infusion of Ang-II, to determine ACE activity in the failing and non-failing hearts.
Determination of Catecholamine Uptake in Denervated (OHT) hearts using radio labelled [3H] nor-epinephrine.
Acute ‘Withdrawal Of Beta-Adrenergic Blockade’ (WOBAB) trail; Clinical, ETT-VO2 and hemodynamic evaluation post-acute withdrawal.
‘Bucindolol Efficacy and Safety Trail’ (BEST).
‘Brain Natriuretic Peptide’ infusion studies, with evaluation of neurohormonal and hemodynamic effects on pulmonay, systemic, cardiac and renal circulation.
Study of Anti-Beta receptor antibodies inhibiting ICYP Radio isotope labelled Iodinated Pindolol binding to human cardiac Beta receptors.
Effect of Gpp(NH)p on Guanidine-Adenyl cyclase complex of cardiac Beta receptors. Study of Radio-ligand binding and receptor down regulation by Gpp(NH)p.
Use of -ISA and non-ISA compounds to observe Beta-receptor response in isolated human cardiac muscle strips from explanted hearts in isometric saline bath.
Forskolin mediated stimulation of adenyl cyclase in explanted cardiac myocytes from Idiopathic and ischemic CMP.
